{"id":10105,"date":"2020-07-13T13:58:54","date_gmt":"2020-07-13T19:58:54","guid":{"rendered":"https:\/\/crism.ca\/?page_id=10105"},"modified":"2026-09-23T10:59:41","modified_gmt":"2026-09-23T16:59:41","slug":"covid-19-pandemic","status":"publish","type":"page","link":"https:\/\/crism.ca\/fr\/covid-19-pandemic\/","title":{"rendered":"Pand\u00e9mie de COVID-19"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Research on COVID-19 Pandemic<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The following research projects were rapidly established to explore how COVID-19 impacts people who use drugs (PWUD). The findings will help inform future research and guidance for healthcare professionals, service providers, and policymakers.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tAdditional resources for clinical and operational settings<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\tRapid Assessment:
Impact of COVID-19
on PWUD in Canada\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CRISM is conducting two studies on COVID-19\u2019s impact on people who use drugs (PWUD) to identify areas of most urgent need, make recommendations for improvements to services, and inform strategies for future pandemics. The studies will deliver a rapid assessment report for decision makers and service providers, and will be followed by development of peer-reviewed publications and evaluation activities.<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\tQuantitative Evaluation
Using Ongoing Prospective
Cohort Studies (300-500 interviews)\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

A nationally developed COVID-19 survey will be administered to PWUD already enrolled in four ongoing Canadian cohort studies: HepCo<\/a>, OiSIS-Toronto,\u00a0VIDUS<\/a>,\u00a0ACCESS<\/a> and ARYS<\/a>. These quantitative studies will help to identify and assess the impacts of local harm reduction or health service interventions that are available to PWUD, as the government\u2019s response to the COVID-19 pandemic evolves.<\/p><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\tIn-Depth Qualitative
Interviews\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Semi-structured interviews with PWUD across the country have documented a myriad of serious impacts of the COVID-19 pandemic on their health and well-being. This national qualitative research study identified issues PWUD are experiencing during the COVID crisis and have made recommendations to change services to respond to the most urgent needs.<\/p>

From May to July, 2020, we conducted 200 interviews with people who live in BC, the Prairies, Ontario, Quebec, and the Atlantic provinces. The final report can be found here.<\/strong><\/a><\/span><\/p>

An article documenting the impacts of COVID-19 on substance use and supply, titled Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada<\/i> can be found here.<\/a><\/strong><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Final report (EN)<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Research on COVID-19 Pandemic The following research projects were rapidly established to explore how COVID-19 impacts people who use drugs (PWUD). The findings will help inform future research and guidance for healthcare professionals, service providers, and policymakers. Additional resources for clinical and operational settings Rapid Assessment:Impact of COVID-19 on PWUD in Canada CRISM is conducting two studies on COVID-19\u2019s impact on people who use drugs (PWUD) to identify areas of most urgent need, make recommendations for improvements to services, and inform strategies for future pandemics. The studies will deliver a rapid assessment report for decision makers and service providers, and will be followed by development of peer-reviewed publications and evaluation activities. Quantitative EvaluationUsing Ongoing ProspectiveCohort Studies (300-500 interviews) A nationally developed COVID-19 survey will be administered to PWUD already enrolled in four ongoing Canadian cohort studies: HepCo, OiSIS-Toronto,\u00a0VIDUS,\u00a0ACCESS and ARYS. These quantitative studies will help to identify and assess the impacts of local harm reduction or health service interventions that are available to PWUD, as the government\u2019s response to the COVID-19 pandemic evolves. In-Depth QualitativeInterviews Semi-structured interviews with PWUD across the country have documented a myriad of serious impacts of the COVID-19 pandemic on their health and well-being. This national qualitative research study identified issues PWUD are experiencing during the COVID crisis and have made recommendations to change services to respond to the most urgent needs. From May to July, 2020, we conducted 200 interviews with people who live in BC, the Prairies, Ontario, Quebec, and the Atlantic provinces. The final report can be found here. An article documenting the impacts of COVID-19 on substance use and supply, titled Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada can be found here. Final report (EN)<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":"","_members_access_role":[],"_members_access_error":"","_links_to":"","_links_to_target":""},"folder":[],"wf_page_folders":[365],"class_list":["post-10105","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nCOVID-19 Pandemic - CRISM<\/title>\n<meta name=\"description\" content=\"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crism.ca\/fr\/covid-19-pandemic\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 Pandemic - CRISM\" \/>\n<meta property=\"og:description\" content=\"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crism.ca\/fr\/covid-19-pandemic\/\" \/>\n<meta property=\"og:site_name\" content=\"CRISM\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-23T16:59:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/coronavirus-gray-background-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1810\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/\",\"url\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/\",\"name\":\"COVID-19 Pandemic - CRISM\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/crism.ca\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/coronavirus-gray-background-scaled.jpg\",\"datePublished\":\"2020-07-13T19:58:54+00:00\",\"dateModified\":\"2026-09-23T16:59:41+00:00\",\"description\":\"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/crism.ca\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/coronavirus-gray-background-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/crism.ca\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/coronavirus-gray-background-scaled.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/crism.ca\\\/covid-19-pandemic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/crism.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19 Pandemic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/crism.ca\\\/#website\",\"url\":\"https:\\\/\\\/crism.ca\\\/\",\"name\":\"CRISM\",\"description\":\"Canadian Research Initiative in Substance Matters\",\"publisher\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/crism.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/crism.ca\\\/#organization\",\"name\":\"Canadian Research Initiative in Substance Matters\",\"url\":\"https:\\\/\\\/crism.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/crism.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/crism.ca\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/crism_long_en.png\",\"contentUrl\":\"https:\\\/\\\/crism.ca\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/crism_long_en.png\",\"width\":1127,\"height\":315,\"caption\":\"Canadian Research Initiative in Substance Matters\"},\"image\":{\"@id\":\"https:\\\/\\\/crism.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/crism-icris\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 Pandemic - CRISM","description":"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crism.ca\/fr\/covid-19-pandemic\/","og_locale":"fr_CA","og_type":"article","og_title":"COVID-19 Pandemic - CRISM","og_description":"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.","og_url":"https:\/\/crism.ca\/fr\/covid-19-pandemic\/","og_site_name":"CRISM","article_modified_time":"2026-09-23T16:59:41+00:00","og_image":[{"width":1810,"height":2560,"url":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/coronavirus-gray-background-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/crism.ca\/covid-19-pandemic\/","url":"https:\/\/crism.ca\/covid-19-pandemic\/","name":"COVID-19 Pandemic - CRISM","isPartOf":{"@id":"https:\/\/crism.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crism.ca\/covid-19-pandemic\/#primaryimage"},"image":{"@id":"https:\/\/crism.ca\/covid-19-pandemic\/#primaryimage"},"thumbnailUrl":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/coronavirus-gray-background-scaled.jpg","datePublished":"2020-07-13T19:58:54+00:00","dateModified":"2026-09-23T16:59:41+00:00","description":"CRISM COVID-19 rapid guidance for substance use care, including harm reduction, telemedicine, and clinical recommendations for providers.","breadcrumb":{"@id":"https:\/\/crism.ca\/covid-19-pandemic\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crism.ca\/covid-19-pandemic\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/crism.ca\/covid-19-pandemic\/#primaryimage","url":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/coronavirus-gray-background-scaled.jpg","contentUrl":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/coronavirus-gray-background-scaled.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/crism.ca\/covid-19-pandemic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/crism.ca\/"},{"@type":"ListItem","position":2,"name":"COVID-19 Pandemic"}]},{"@type":"WebSite","@id":"https:\/\/crism.ca\/#website","url":"https:\/\/crism.ca\/","name":"CRISM","description":"Canadian Research Initiative in Substance Matters","publisher":{"@id":"https:\/\/crism.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crism.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/crism.ca\/#organization","name":"Canadian Research Initiative in Substance Matters","url":"https:\/\/crism.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/crism.ca\/#\/schema\/logo\/image\/","url":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/crism_long_en.png","contentUrl":"https:\/\/crism.ca\/wp-content\/uploads\/2025\/08\/crism_long_en.png","width":1127,"height":315,"caption":"Canadian Research Initiative in Substance Matters"},"image":{"@id":"https:\/\/crism.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/crism-icris"]}]}},"_links":{"self":[{"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/pages\/10105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/comments?post=10105"}],"version-history":[{"count":46,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/pages\/10105\/revisions"}],"predecessor-version":[{"id":25557,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/pages\/10105\/revisions\/25557"}],"wp:attachment":[{"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/media?parent=10105"}],"wp:term":[{"taxonomy":"folder","embeddable":true,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/folder?post=10105"},{"taxonomy":"wf_page_folders","embeddable":true,"href":"https:\/\/crism.ca\/fr\/wp-json\/wp\/v2\/wf_page_folders?post=10105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}